Clinical Assays

Real-time actionable insights in native conditions

Patient selection panel

Derisk clinical trials before they start. Increase the patient engagement, safety and efficacy.

Biomarker expression

Measure the relevant biomarker in patient samples

Immunogenicity – ADA

Prevent selecting patients with pre-existing Anti-drug antibody immunogenicity

Functional

Cell based assaysADCC, ADCP, …
Cytokine level

EARly de-risking in clinical trial

TDM panel

Adaptive dosing and Informed treatment decision. Maximize clinical outcome, patient benefit & relevant data for regulatory filings.

Through level

Personalized dose adjustment near point of care

Immunogenicity – ADA

Profile and prevent immunogenicity by
-ADA & nAb
-ADA & maturation
-ADA & unwanted immune responses
–ADA & isotyping

Cell-based assays

Assess the effect, either targeted or unwanted, of your therapeutic on the patient immune system.

Companion Dx

Monitor your biomarker levels and link to clinical result

Want to know more?

Take action today and embark on an exciting journey to achieve your goals. Let us guide you through the process and help you unleash your true potential.